When the inter-treatment interval was extended to 2 weeks, delivering more than one dose of doxorubicin also contributed to limited tumor cell growth ( p < 0.05, see Supplementary Table S21 ); however, most of the replicates showed an increasing trend in total tumor cell count over the experiment duration.
← all excerpts
Mathematical characterization of population dynamics in breast cancer cells treated with doxorubicin.
1
—
—